Orally supplemented lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice

Microbiology and Immunology

Volumn 54, Issue 9, 2010, Pages 523-533

  Shah, Mohammad Monir ^a   Miyamoto, Yoshihiro ^b   Yamada, Yoshihito ^b   Yamashita, Hirotaka ^a,b   Tanaka, Hiroyuki ^a,b   Ezaki, Takayuki ^a   Nagai, Hiroichi ^b   Inagaki, Naoki ^a,b  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

2,4 dinitroflurobenzene; Atopic dermatitis; Lactobacillus acidophilus strain L 92; Mite fecal antigen

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; BETA ACTIN; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PROBIOTIC AGENT; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ATOPIC DERMATITIS; BACTERIAL STRAIN; BLOOD VESSEL PERMEABILITY; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFICACY; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN PRODUCTION; INHIBITION KINETICS; LACTIC ACID BACTERIUM; LACTOBACILLUS ACIDOPHILUS; MALE; MAST CELL; MOUSE; NONHUMAN; OTITIS; PASSIVE SKIN ANAPHYLAXIS; PROTEIN EXPRESSION; SCRATCHING; SKIN ANAPHYLAXIS; SYMPTOM; TH1 CELL; TH2 CELL; ANAPHYLAXIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DERMATITIS, ATOPIC; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; ORAL DRUG ADMINISTRATION; TOXICITY;

ADMINISTRATION, ORAL; ANAPHYLAXIS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CYTOKINES; DERMATITIS, ATOPIC; DINITROFLUOROBENZENE; FEMALE; IMMUNOGLOBULIN E; LACTOBACILLUS ACIDOPHILUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; PASSIVE CUTANEOUS ANAPHYLAXIS; TH1 CELLS; TH2 CELLS;

ACARI; ANIMALIA; DERMATOPHAGOIDES FARINAE; LACTOBACILLUS ACIDOPHILUS; MUS;

EID: 77957917461     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00251.x     Document Type: Article

References (45)

1. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. (2003) New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37: 105-18.
2. Murosaki S., Yamamoto Y., Ito K., Inokuchi T., Kusaka H., Ikeda H., Yoshikai Y. (1998) Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol 102: 57-64.
3. Fujiwara D., Inoue S., Wakabayashi H., Fujii T. (2004) The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 135: 205-15.
4. Grewe M., Bruijnzeel-Koomen C.A., Schöpf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., Krutmann J. (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19: 359-61.
5. Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. (2004) New insights into atopic dermatitis. J Clin Invest 113: 651-57.
6. Sicherer S.H., Leung D.Y. (2009) Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008. J Allergy Clin Immunol 123: 319-27.
7. Wahlgren C.F. (1999) Itch and atopic dermatitis: an overview. J Dermatol 26: 770-79.
8. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-71.
9. Weston S., Halbert A., Richmond P., Prescott S.L. (2005) Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90: 892-97.
10. Shida K., Takahashi R., Iwadate E., Takamizawa K., Yasui H., Sato T., Habu S., Hachimura S., Kaminogawa S. (2002) Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 32: 563-70.
11. Segawa S., Hayashi A., Nakakita Y., Kaneda H., Watari J., Yasui H. (2008) Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biol Pharm Bull 31: 884-89.
12. Wakabayashi H., Nariai C., Takemura F., Nakao W., Fujiwara D. (2008) Dietary supplementation with lactic acid bacteria attenuates the development of atopic-dermatitis-like skin lesions in NC/Nga mice in a strain-dependent manner. Int Arch Allergy Immunol 145: 141-51.
13. Sunada Y., Nakamura S., Kamei C. (2008) Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 20: 1761-66.
14. Kalliomäki M., Salminen S., Poussa T., Isolauri E. (2007) Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119: 1019-21.
15. Ishida Y., Nakamura F., Kanzato H., Sawada D., Hirata H., Nishimura A., Kajimoto O., Fujiwara S. (2005) Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 88: 527-33.
16. Ishida Y., Nakamura F., Kanzato H., Sawada D., Yamamoto N., Kagata H., Oh-Ida M., Takeuchi H., Fujiwara S. (2005) Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem 69: 1652-60.
17. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., Nagai H. (2007) Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 56: 293-301.
18. Inagaki N., Shibata T., Itoh T., Suzuki T., Tanaka H., Nakamura T., Akiyama Y., Kawagishi H., Nagai H. (2005) Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus. Evid Based Complement Alternat Med 2: 369-74.
19. Inagaki N., Igeta K., Shiraishi N., Kim J.F., Nagao M., Nakamura N., Nagai H. (2003) Evaluation and characterization of mouse scratching behavior by a new apparatus, MicroAct. Skin Pharmacol Appl Skin Physiol 16: 165-75.
20. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121: 850-56.
21. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., van der Heide S., Jansen D.F., Hoijer M.A., Kauffman H.F., Duiverman E.J. (2006) No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36: 899-906.
22. Taylor A.L., Dunstan J.A., Prescott S.L. (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119: 184-91.
23. Smits H.H., Engering A., Van Der Kleij D., de Jong E.C., Schipper K., van Capel T.M., Zaat B.A., Yazdanbakhsh M., Wierenga E.A., van Kooyk Y., Kapsenberg M.L. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115: 1260-67.
24. Fang S.B., Lee H.C., Hu J.J., Hou S.Y., Liu H.L., Fang H.W. (2009) Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J Trop Pediatr 55: 297-301.
25. Kataria J., Li N., Wynn J.L., Neu J. (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67: 546-50.
26. Li N., Russell W.M., Douglasescobar M., Hauser N., Lopez M., Neu J. (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res. 66: 203-7.
27. Galdeano C.M., Perdigón G. (2006) The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13: 219-26.
28. Shimosato T., Kitazawa H., Katoh S., Tohno M., Iliev I.D., Nagasawa C., Kimura T., Kawai Y., Saito T. (2005) Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling. Biochem Biophys Res Commun 326: 782-87.
29. Petersen L.J., Mosbech H., Skov P.S. (1996) Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 97: 672-79.
30. Inagaki N., Goto S., Yamasaki M., Nagai H., Koda A. (1986) Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Int Arch Allergy Appl Immunol 80: 285-90.
31. Inagaki N., Miura T., Nagai H., Koda A. (1992) Active cutaneous anaphylaxis (ACA) in the mouse ear. Jpn J Pharmacol 59: 201-8.
32. Takeshita K., Yamasaki T., Akira S., Gantner F., Bacon K.B. (2004) Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16: 685-95.
33. Kitagaki H., Ono N., Hayakawa K., Kitazawa T., Watanabe K., Shiohara T. (1997) Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 159: 2484-91.
34. Thomas W.R., Smith W.A., Hales B.J., Mills K.L., O'Brien R.M. (2002) Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 129: 1-18.
35. Takano N., Sakurai T., Kurachi M. (2005) Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci 99: 277-86.
36. Inagaki N., Shiraishi N., Igeta K., Itoh T., Chikumoto T., Nagao M., Kim J.F., Nagai H. (2006) Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 546: 189-96.
37. Ständer S., Steinhoff M., Schmelz M., Weisshaar E., Metze D., Luger T. (2003) Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 139: 1463-70.
38. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., Geha R.S. (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103: 1103-11.
39. Grewe M., Gyufko K., Schöpf E., Krutmann J. (1994) Lesional expression of interferon-gamma in atopic eczema. Lancet 343: 25-26.
40. Maassen C.B., van Holten-Neelen C., Balk F., den Bak-Glashouwer M.J., Leer R.J., Laman J.D., Boersma W.J., Claassen E. (2000) Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18: 2613-23.
41. Ghadimi D., Fölster-Holst R., de Vrese M., Winkler P., Heller K.J., Schrezenmeir J. (2008) Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213: 677-92.
42. Lack G., Renz H., Saloga J., Bradley K.L., Loader J., Leung D.Y., Larsen G., Gelfand E.W. (1994) Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol 152: 2546-54.
43. Parronchi P., De Carli M., Manetti R., Simonelli C., Sampognaro S., Piccinni M.P., Macchia D., Maggi E., Del Prete G., Romagnani S. (1992) IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 149: 2977-83.
44. Pène J., Rousset F., Brière F., Chrétien I., Bonnefoy J.Y., Spits H., Yokota T., Arai N., Arai K., Banchereau J., DeVries J.E. (1988) IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 85: 6880-4.
45. Nagai H., Hiyama H., Matsuo A., Ueda Y., Inagaki N., Kawada K. (1997) FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. J Pharmacol Exp Ther 283: 321-27.